Success Metrics

Active Trials
4(67%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_1
4
67%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Other(1)

Detailed Status

Recruiting4
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
4
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 14 (66.7%)
Phase 22 (33.3%)

Trials by Status

recruiting467%
unknown117%
not_yet_recruiting117%

Recent Activity

4 active trials
Showing 5 of 6
recruitingphase_2

Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma

NCT06746480
recruitingphase_2

Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

NCT06126510
recruitingphase_1

Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer

NCT04806464
not_yet_recruitingphase_1

Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma

NCT06124001
recruitingphase_1

Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer

NCT06008925
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06746480Phase 2

Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma

Recruiting
NCT06126510Phase 2

Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

Recruiting
NCT04806464Phase 1

Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer

Recruiting
NCT06124001Phase 1

Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma

Not Yet Recruiting
NCT06008925Phase 1

Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer

Recruiting
NCT04758897Phase 1

Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6